En Es
Products
Covid-19
Companies
Pre-Owned
News
Events
About Us       Join now!
Categories

Browse Products by Category

Critical Care

Emergency Medicine

Intensive Care

Respiratory Care

Anesthesiology Systems

Home Care

Rehabilitation

Other

Hospital Infrastructure

IT Equipment

Transportation Systems

Waste Management

Other

Medical Imaging

Computed Tomography

Digital Radiography

Image Management Systems

Interventional Radiology

Magnetic Resonance Imaging

Mammography

PACS/RIS

Positron Emission Tomography

Radiation Safety

Radiography

Single-Photon Emission Computed Tomography

Ultrasound

Other

Patient Care

Bariatric Care

Beds

Examination Equipment

Other

Surgery

Endoscopy

Laparoscopy

Laser Surgery

Operating Room Equipment

Sterilization

Surgical Implants

Surgical Instruments

Waste Management

Other

Expo: Clinical Laboratory

Blood/Gas Analyzers

Cell Counters

Centrifuges

Clinical Chemistry Analyzer

Coagulation Analyzers

General Lab

Hematology Analyzers

Immunoassay Systems

Lab Glassware

Microplate Reader

Microscopes

Pipettes

Rapid Tests

Ready-to-use Kits for Analysis

Urine Analyzer

Browse Products by Category

Close

Abbott Diagnostics

Abbott Diagnostics provides medical diagnostic instruments, tests, automation and informatics solutions, including clinical chemistry and immunoassay analyzers and hematology solutions. The company’s offerings are ideal for hospitals, reference labs, molecular labs, blood banks, physician offices and clinics.
Gold member
Products Covid-19Summary
Close

Covid-19 Abbott Diagnostics

Clinical Laboratory

Molecular Diagnostics System
ID NOW

The ID NOW is a rapid, instrument-based, isothermal system for the qualitative detection of infectious diseases and uses isothermal nucleic acid amplification technology for providing molecular results in minutes. The intuitively designed instrument features a large visual touchscreen for displaying the results, eliminating transcription errors and the need for printing, while its small footprint saves bench space for use in any healthcare setting.
More details

COVID-19 Antigen Test
BinaxNOW COVID-19 Ag Card

The BinaxNOW COVID-19 Ag Card rapid antigen test, which has received emergency use authorization (EUA) from the US Food and Drug Administration (FDA), offers results in 15 minutes and is available as an aid to diagnose the virus that causes COVID-19. The BinaxNOW test can be displayed on Abbott’s new optional app - available at no charge - for iPhone and Android devices called NAVICA. This first-of-its-kind app will allow people who test negative to have a temporary encrypted digital health pass that displays their results.
More details

COVID-19 Antigen Test
Panbio COVID-19 Ag Rapid Test Device

The Panbio COVID-19 Ag Rapid Test Device is intended for patients suspected of current COVID-19 infection and identifies potentially contagious patients in 15 minutes. Using patient-friendly nasal or nasopharyngeal sample collection types, the high performance rapid test enables immediate treatment or isolation measures to minimize transmission. The product is not available in all countries and available in select markets.
More details

COVID-19 Test
ID NOW COVID-19

The ID NOW COVID-19 test returns positive results in 13 minutes or less to enable immediate clinical decisions during the first patient visit. The easy to use ID NOW platform is designed for near-patient, point-of-care use in a variety of healthcare settings.
More details

COVID-19 Anitibody Test
Panbio COVID-19 IgG/IgM Rapid Test Device

The Panbio COVID-19 IgG/IgM Rapid Test Device is an in vitro diagnostic rapid test for the qualitative detection of IgG and IgM antibodies to SARS-CoV-2 in human serum, plasma, venous and fingerstick whole blood. The test provides preliminary test results within 10-20 minutes and is not intended to be used as a donor screening test for SARS-CoV-2. The product is not available in all countries and available in select markets.
More details

SARS-CoV-2 Antibody Test
Panbio SARS-CoV-2 IgG ELISA

The Panbio SARS-CoV-2 IgG ELISA is an antibody test that helps identify individuals with immune response to SARS-CoV-2 and enables greater access for broad population surveillance. The test is compatible with manual ELISA, and is adaptable to semi-automated and fully-automated equipment, enabling easy deployment within a lab's existing infrastructure. The product is not available in all countries and available in select markets.
More details

SARS-CoV-2 IgG Immunoassay
SARS-CoV-2 IgG II Quant

The SARS-CoV-2 IgG II Quant assay is a chemiluminescent microparticle immunoassay (CMIA) used for the qualitative and quantitative determination of IgG antibodies to SARS-CoV-2 in human serum and plasma on the Alinity and ARCHITECT i Systems. The assay is to be used as an aid in the diagnosis of SARS-CoV-2 infection in conjunction with clinical presentation and other laboratory tests. The assay is also to be used as an aid in evaluating immune status of infected individuals and to monitor antibody response in individuals that have received the COVID-19 vaccine, by quantitatively measuring IgG antibodies against the spike receptor-binding domain (RBD) of SARS-CoV-2.
More details

Molecular Diagnostics Analyzer
ALINITY m

The ALINITY m is a fully integrated and automated molecular diagnostics analyzer that uses innovative technology to deliver the next level of flexibility and efficiency to the lab. With its Readiflex technology, 20 onboard assay capacity and broad assay menu, the allows consolidation of 60% of routine PCR testing on one instrument.
More details

SARS-CoV-2 Assay
Abbott RealTime SARS-CoV-2 Assay

The Abbott RealTime SARS-COV-2 Assay is a real-time (rt) reverse transcriptase (RT) polymerase chain reaction (PCR) test intended for the qualitative detection of nucleic acids from the SARS-CoV-2 in nasopharyngeal and oropharyngeal swabs from patients who are suspected of COVID-19 by their healthcare provider. Engineered with dual target assay for RdRp and N-genes, it provides a fully automated solution to help laboratories address the urgent need for patient testing during the Coronavirus (COVID-19) pandemic.
More details

Sample Preparation System
m24sp

The m24sp is an instrument for laboratories with mid-throughput requirements that offers automated flexibility. An automated bench-top system with a small footprint, the m24sp features reliable extraction using mSample Preparation chemistry and variable extraction with ready-to-use and re-usable reagents plus flexible batch size.
More details

SARS-CoV-2 Antibody Test
AdviseDx SARS-CoV-2 IgM Assay

The AdviseDx SARS-CoV-2 IgM assay is a chemiluminescent microparticle immunoassay (CMIA) intended for the qualitative detection of IgM antibodies to SARS-CoV-2 in human serum, serum separator tube and plasma (dipotassium EDTA, tripotassium EDTA, lithium heparin, lithium heparin separator tube, sodium heparin). The assay is intended for use as an aid in identifying individuals with an adaptive immune response to SARS-CoV-2, indicating recent or prior infection and should not be used to diagnose acute SARS-CoV-2 infection.
More details

SARS-CoV-2 Antibody Test
SARS-CoV-2 IgG Assay

The SARS-CoV-2 IgG assay is a chemiluminescent microparticle immunoassay (CMIA) intended for the qualitative detection of IgG antibodies to SARS-CoV-2 in human serum, serum separator tube and plasma (ACD, CPD, CPDA-1, dipotassium EDTA, tripotassium EDTA, lithium heparin, lithium heparin separator tube, sodium citrate, sodium heparin). The assay is intended for use as an aid in identifying individuals with an adaptive immune response to SARS-CoV-2, indicating recent or prior infection and should not be used to diagnose acute SARS-CoV-2 infection.
More details

SARS-CoV-2 Assay
Alinity m SARS-CoV-2 Assay

The Alinity m SARS-CoV-2 Assay is a real-time (rt) reverse transcriptase (RT) polymerase chain reaction (PCR) test intended for the qualitative detection of nucleic acid from the SARS-CoV-2 in nasopharyngeal and oropharyngeal swabs collected by a healthcare provider, from patients who are suspected of COVID-19 infection. The assay runs on the Alinity m system having a simple workflow with primary sample tube loading to provide operational efficiencies to curb the increasing testing volume with the existing lab staff.
More details

Critical Care

Molecular Diagnostics System
ID NOW

The ID NOW is a rapid, instrument-based, isothermal system for the qualitative detection of infectious diseases and uses isothermal nucleic acid amplification technology for providing molecular results in minutes. The intuitively designed instrument features a large visual touchscreen for displaying the results, eliminating transcription errors and the need for printing, while its small footprint saves bench space for use in any healthcare setting.
More details

COVID-19 Antigen Test
BinaxNOW COVID-19 Ag Card

The BinaxNOW COVID-19 Ag Card rapid antigen test, which has received emergency use authorization (EUA) from the US Food and Drug Administration (FDA), offers results in 15 minutes and is available as an aid to diagnose the virus that causes COVID-19. The BinaxNOW test can be displayed on Abbott’s new optional app - available at no charge - for iPhone and Android devices called NAVICA. This first-of-its-kind app will allow people who test negative to have a temporary encrypted digital health pass that displays their results.
More details

COVID-19 Antigen Test
Panbio COVID-19 Ag Rapid Test Device

The Panbio COVID-19 Ag Rapid Test Device is intended for patients suspected of current COVID-19 infection and identifies potentially contagious patients in 15 minutes. Using patient-friendly nasal or nasopharyngeal sample collection types, the high performance rapid test enables immediate treatment or isolation measures to minimize transmission. The product is not available in all countries and available in select markets.
More details

COVID-19 Test
ID NOW COVID-19

The ID NOW COVID-19 test returns positive results in 13 minutes or less to enable immediate clinical decisions during the first patient visit. The easy to use ID NOW platform is designed for near-patient, point-of-care use in a variety of healthcare settings.
More details
Close

About Abbott Diagnostics

Abbott Diagnostics provides medical diagnostic instruments, tests, automation and informatics solutions, including clinical chemistry and immunoassay analyzers and hematology solutions. The company’s offerings are ideal for hospitals, reference labs, molecular labs, blood banks, physician offices and clinics.
FaceBook Twitter Google+ Linked in
POC Management Solutions

POC Management Solutions

Model: AegisPOC
Request Information

Description:

The AegisPOC Point of Care Management Solutions is a web-based, open platform which connects point-of-care (POC) devices located in the hospital or community with the laboratory. It allows the laboratory to better manage and share data from POC devices on one flexible, scalable middleware.

Tags: [Critical Care], [Hospital Infrastructure], [IT Equipment], [Network Solutions/Communication Systems], [Point of Care]
Features

Features

• Results, QC, and Instrument Management
• Operator and Certification Management
• Patient Management
• Audit Logging
• Workstation Management
• System Settings
• Wide range of reports
• Secure data center hosting
• Minimized search time through the use of smart filters
• Remote operator management through network tools
• Ability to update, manage and troubleshoot operator and device issues from nursing units Request Information

Send A Message To This Supplier

* Required Information
* Email
To
Abbott Diagnostics (POC Management Solutions)
* Message

More Products From This Supplier

Hematology Analyzer
CELL-DYN Emerald
Hematology System
CELL-DYN Emerald 22
Immunoassay Analyzer
ARCHITECT i1000SR
Molecular Diagnostics System
ID NOW
Strep A Test
ID NOW Strep A 2
Blood Analyzer
i-STAT Alinity
Lab Automation System
ACCELERATOR a3600
Malaria Test
BinaxNOW Malaria
Copyright © 2000-2022 TradeMed.com. All rights reserved. | Terms And Conditions